These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19162082)

  • 1. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
    Thiemann G; Watt CA; Ledent C; Molleman A; Hasenöhrl RU
    Behav Brain Res; 2009 Jun; 200(1):60-7. PubMed ID: 19162082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic versus pharmacological invalidation of the cannabinoid CB(1) receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice.
    Thiemann G; Fletcher BC; Ledent C; Molleman A; Hasenöhrl RU
    Neurobiol Learn Mem; 2007 Nov; 88(4):416-23. PubMed ID: 17884611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization.
    Thiemann G; van der Stelt M; Petrosino S; Molleman A; Di Marzo V; Hasenöhrl RU
    Behav Brain Res; 2008 Mar; 187(2):289-96. PubMed ID: 17988751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
    Rodgers RJ; Evans PM; Murphy A
    Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of (Z)-3-hexenol, a major component of green odor, on anxiety-related behavior of the mouse in an elevated plus-maze test and biogenic amines and their metabolites in the brain.
    Tokumo K; Tamura N; Hirai T; Nishio H
    Behav Brain Res; 2006 Jan; 166(2):247-52. PubMed ID: 16214236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.
    Haller J; Varga B; Ledent C; Freund TF
    Behav Pharmacol; 2004 Jul; 15(4):299-304. PubMed ID: 15252281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover.
    Darmani NA; Janoyan JJ; Kumar N; Crim JL
    Pharmacol Biochem Behav; 2003 Jul; 75(4):777-87. PubMed ID: 12957219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration, population, and context-dependent effects of AM251 in zebrafish.
    Tran S; Chatterjee D; Facciol A; Gerlai R
    Psychopharmacology (Berl); 2016 Apr; 233(8):1445-54. PubMed ID: 26883874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid CB₁ receptor in the modulation of stress coping behavior in mice: the role of serotonin and different forebrain neuronal subpopulations.
    Häring M; Grieb M; Monory K; Lutz B; Moreira FA
    Neuropharmacology; 2013 Feb; 65():83-9. PubMed ID: 23000076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
    Nawata Y; Hiranita T; Yamamoto T
    Neuropsychopharmacology; 2010 Jan; 35(2):515-20. PubMed ID: 19829291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
    Haller J; Bakos N; Szirmay M; Ledent C; Freund TF
    Eur J Neurosci; 2002 Oct; 16(7):1395-8. PubMed ID: 12405999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neurobiol Dis; 2009 Oct; 36(1):70-80. PubMed ID: 19591935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour.
    Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D
    Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
    Takahashi RN; Pamplona FA; Fernandes MS
    Neurosci Lett; 2005 Jun; 380(3):270-5. PubMed ID: 15862900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.
    Griebel G; Stemmelin J; Scatton B
    Biol Psychiatry; 2005 Feb; 57(3):261-7. PubMed ID: 15691527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of Serotonin 2C Receptors with SB-242084 Moderates Reduced Locomotor Activity and Rearing by Cannabinoid 1 Receptor Antagonist AM-251.
    Bogáthy E; Kostyalik D; Petschner P; Vas S; Bagdy G
    Pharmacology; 2019; 103(3-4):151-158. PubMed ID: 30673678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.